This document provides information about India's National Immunization Programme (UIP). It discusses the targeted vaccine preventable diseases (VPDs), the history and objectives of the Expanded Programme on Immunization (EPI) and Universal Immunization Programme (UIP). It outlines the national immunization schedule, components of UIP including vaccination of pregnant women and children, and strategies to achieve coverage goals. Coverage levels from surveys are presented. The document also discusses vaccine administration techniques for different vaccines.

1. PG STUDENT : Dr. AMOL ASKAR.
PG TEACHER : Dr. Lalit sankhe.
: Dr. Amit Mohite.
1
*NATIONAL IMMUNIZATION
PROGRAMME

2. Contents of seminar
1) Introduction to VPDs
2) EPI :- World & India
3) UIP
 Milestones
 Objective
 Components
 Micro planning
 Coverage
 Schedule
 Constraints
 Achievements

3. 4) Status of VPDs
5) Pulse polio immunisation
6) Mission Indradhanush.

4. Vaccine Preventable Diseases
An infectious disease for which an effective preventive
vaccine exists.
If a person dies from it, the death is considered a vaccine-
preventable death.

5. TARGETED VPDS
Tuberculosis
Diphtheria
Pertussis
Poliomyelitis
Measles
Tetanus
Hepatitis B
Japanese Encephalitis

6. TUBERCULOSIS

7. DIPHTHERIA

8. PERTUSSIS

9. POLIOMYELITIS

10. MEASLES

11. TETANUS

12. FULLY IMMUNIZED CHILD
A child who received
One dose of BCG,
Three doses of DPT and OPV,
One dose of measles
before one year of age.
This gives a child the best chance for survival.

13. Control
 Reduction of prevalence or incidence of disease to lower acceptable level.
Elimination
 Eradication of disease from a large geographic region or political jurisdiction
 Either reduction of infectious disease’s prevalence in regional population to
zero or reduction of global prevalence to a negligible amount.
Eradication
 Termination of all transmissions of infection by extermination of infectious
agent through surveillance and containment.
 Reduction of infectious disease’s prevalence in global host population to
zero.

14. EXPANDED PROGRAMME ON IMMUNISATION (EPI)
EPI launched in 1974
Build on smallpox infrastructure
Targeted 6 diseases
EPI progressively adopted by all countries
Universal by early 1098s

15. Original EPI infant schedule.
Age
Vaccines
Birth 6 weeks 10 weeks 14
weeks
9
months
BCG BCG
OPV OPV 1 OPV 2 OPV 3
DPT DPT 1 DPT 2 DPT 3
Measles Measles

16. Addition to EPI
 Yellow fever in 1988
• For endemic countries only : 33 in Africa, 11 in S. America.
• Given with measles vaccine
 Hepatitis B in 1992
• In high seroprevalence countries by 1995
• In all countries by 1997
 Haemophilus influenzae type b (Hib)
• 1998 : based on disease burden and capacity
• 2006 : all countries. ( lack of data should not be obstacle)

17. 3 slides of coverage fm unicef

18. 3 slides of coverage fm unicef

19. 3 slides of coverage fm unicef

20. EPI IN INDIA
The Govt of India launched it’s EPI in 1978.
Introduced BCG, OPV, DPT, & Typhoid-paratyphoid vaccines
Objectives
 To reducing mortality, morbidity resulting from VPDs.
 To achieve a self sufficiency in vaccine production.

21.  Target :- at least 80% coverage in infancy.
 As vaccination was offered through major hospitals & largely restricted to
urban areas so coverage remained low.
 In 1981 Typhoid-paratyphoid vaccine was dropped from EPI due to
--- Considered higher reactogenicity and low efficacy of the vaccines
--- Perceived reduced burden of typhoid disease in the country.
 In 1983 tetanus toxoid vaccine for pregnant woman added in EPI

22. UNIVERSAL IMMUNIZATION PROGRAMME
Launched on 19 Nov 1985 in
remembrance of then Prime
Minister, Indira Gandhi.

23. MILESTONES IN THE IMMUNIZATION PROGRAM
1978 : Expanded Program of Immunization (EPI) introduced after smallpox
eradication:
BCG, DPT, OPV, Typhoid.
Limited to mainly urban areas
1985 : Universal Immunization Program (UIP) introduced
Expanded to entire country; Measles added.
1986 : National Technology Mission
Objectives
Monitoring under PMO’s 20 point programme
Improve coverage with existing antigens
Develop self sustainability in vaccine production

24. Continued….
1990 : Vitamin-A supplementation.
1992 : Child Survival and Safe Motherhood Program.
1995:- India 1st conducted national immunisation day for polio eradication.
1997:- Reproductive and Child Health Programme
National Polio Surveillance Project launched as WHO & GOI collaboration.
2001:- National Technical Advisory Group On immunisation formed
2005:- National Rural Health Mission

25. OBJECTIVES
1) To increase immunization coverage.
2) To improve quality of service.
3) To achieve self sufficiency in vaccine production &
manufacturing of cold chain equipments.
4) To establish reliable cold chain equipment and establish a
good surveillance network.
5) To introduce a district wise system monitoring & evaluation
6) To train health personnel.

26.  India has one of the largest Universal Immunization Programs (UIP) in the
world in terms of the quantities of vaccines used, number of beneficiaries
covered, geographical spread and human resources involved.
 Under the UIP, all vaccines are given free of cost to the beneficiaries as per
the National Immunization Schedule.
 All beneficiaries can get themselves vaccinated at the nearest
Government/Private health facility or at an immunization post (Anganwadi
centres/ other identified sites) near to their village/urban locality on fixed
days.
 The UIP covers all sections of the society across the country with the same
high quality vaccines.

27. COMPONENTS OF UIP
1. Immunization of pregnant women against tetanus.
2. Immunization of children in their first year of life against 6 VPDs.

28. 2 COMPONENTS OF UIP

29. Aim/ Target :-
 To achieve 100 % coverage of pregnant women with 2 doses of TT.
 At least 85% coverage of children under one year (with 3 doses of DPT, OPV
& one dose of BCG, One dose of Measles) by march 1990.
 Target was increased to cover 100% of infants as the vaccination
programme became universalised in geographical coverage
 UIP was first started in 31 selected districts with plan of scale up to
additional districts.

30. Goal 1
Districts will provide efficient and safe immunization services to all infants and
pregnant woman
Objectives
 Regular quality immunisation sessions are planned and held
 Adequate trained staff are empowered to provide quality immunisation
services
 Annually upgrade cold chain inventory according to levels of network
 Implementation of safe injection practices & waste disposal

31. Strategies
 Coordination between national and state level
 Printing & supply of normal operational guidelines
 Strengthening of supervision
 Prioritization of under served populations within districts
 Strengthening Training of all categories of staff
 Timely supply of vaccines and ensuring quality control of vaccines

32. Goal 2
Contribute global polio eradication, measles mortality reduction and neonatal
tetanus elimination
Objectives
 Polio eradication certification by 2007
 Elimination of neonatal tetanus by 2009
 Reduction in measles mortality by 2/3 compared to 2000 estimates by 2010
 Achieve and maintain 70% coverage of 2 doses of vitamin A to children < 3 yrs

33. Strategies
 Routine immunisation for polio
 Supplementary immunisation activities
 AFP surveillance
 Increasing the reporting and action on cases
 Safe delivery practices
 Strengthening measles vaccination and surveillance and response to
outbreaks

34. Goal 3
UIP will have sufficient and sustainable funding with established adequate,
accountable, efficient fund flows
Objectives
 Adequate & reliable financial resources at national, state and local levels
for the UIP to achieve goals & objectives
 Political commitment for adequate annual funding at all levels
Strategies
 Strengthening national financial planning
 Building partnership

35. Goal 4
Sustain demand & reduce social barriers to access immunisation services
Objectives
 Widespread support by families and communities
 All eligible children & pregnant woman are immunised
 High level political and administrative support
Strategies
 Coverage with print, electronic media,etc.
 Improve interpersonal communication

36. Goal 5
Accelerated introduction of licensed new and under utilized vaccines against
diseases with significant mortality and morbidity in India
Objectives
 Institutional mechanisms in place to adequately obtain, review and utilize
information for deciding on introduction of new and under utilized vaccines
 Review need for MMR or MR vaccines in India’s immunisation program
 Phased introduction of Hepatitis B
Strategies
 Improve coordination between MoHFW, research institutes, NRI,
development partners, surveillance & training.

37. Goal 6
To monitor & use accurate, complete & timely data on vaccine preventable
disease , AEFIs, antigen coverage & drop out rates by district
Objectives
 Institutional surveillance for VPDs & early detection of any outbreaks
 Strengthened vaccine quality and injection safety by developing monitoring
system for reporting & responding to adverse events following immunisation
by 2009
 Effective, efficient complete and timely immunisation, local recording and
area monitoring system by 2009

38. CHANNEL s OF SERVICE PROVISION
Immunization services are provided through the existing Health Care
Delivery System. (MCH centers, PHC, CHCs, Hospitals, Dispensaries).

39. Additional national efforts
 Launch of immunization strengthening project (ISP)
 Urban measles campaign
 Border district cluster strategy (BDCS)
 Celebration of immunization weeks
 The national technical advisory group on immunisation (NTAGI) was formed in
2001 .
 The adverse events following immunisation reporting has been made a part of UIP
since 1985.
• 1st documented AEFI report & guidelines published in 1988
• Guidelines revised and widely disseminated in 2005-06

41.  To strengthen post marketing surveillance for vaccines in India
• Manufacturers are required to submit periodic safety update reports (PSURs) for
all newly licensed vaccines to Central Drug Standard Control Organisation (CDSCO)
every 6 months in 1st two years and then Annually for next 2 years
 India adopted policy of use of auto disable syringes only for UIP in country starting
in 2005-06
 India adopted policy for procuring all vaccines with Vaccine Vial Monitor (VVM) to
monitor potency of the vaccines in field situation
 India released 1st National Vaccine Policy in 2011. policy provides guiding
principles for functioning & strengthening of immunisation programme in country.

43.  The year 2012-13 was declared as “Year of Intensification of Routine
Immunisation” in India.
 There was increased focus on improving coverage in identified 239 poor
performing districts in India.

49. %Infants (0-1 year)reached
100
86.9
69.6 66.2 63.6
54.1
11.3
0
20
40
60
80
100
120
Targetinfants
BCG
Measles
OPV
DPT-3
Fully
immunize
No
immunization
Target infants : 26 million
Fully immunized: 14.1 million
Partial immunized:9.0 million
No immunized: 2.9 million

50. As per the Coverage Evaluation Survey (CES-2009), 61% of children in the
country are Fully Immunized with all vaccines.
Evaluated coverage (%)
District Level Household
Survey 3 (DLHS) 2007-08
Coverage Evaluation Survey
(CES) 2009
Full immunisation 54.1 61.0
BCG 86.9 86.9
OPV3 65.6 70.4
DPT3 63.4 71.5
Measles 69.1 74.1
No immunisation 11.3 7.6

51. Ref:-UNICEF Coverage evaluation survey: all India report 2009.

53. *
Ref:-UNICEF Coverage evaluation survey: all India report 2009.

54. National Immunization Schedule
Age Vaccines
Birth BCG, OPV-O, Hep B
6 weeks DPT -1, OPV -1, Hep B
10 weeks DPT -2, OPV -2, Hep B
14 weeks DPT -3, OPV-3, Hep B
9 months Measles with vitamin A
16-24 months DPT booster 1st , OPV – Booster,
5 years DPT Booster 2nd
10 years TT
16 years TT

55. AGE VACCINES
16-24 months Measles 2nd dose
16-24 months Japanese Encephalitis
18 , 24, 30, 36, 42, 48, 54, 60 months Vitamin A
AGE VACCINES
TT-1 Early in pregnancy
TT-2 4 weeks after TT-1
TT booster if received 2 TT doses in
last pregnancy within last 3 years

56. Vaccines added
 On 2nd July GOI introduced 4 new vaccines on recommendations given by
NTAGI
 ROTAVIRUS
 INJECTABLE POLIO
 RUBELLA
 JAPANEASE ENCEPHALITIS

57. IAP Schedule
VACCINES AGE
BCG Birth – 2 weeks
OPV Birth ; 6,10,14 weeks; 16-18 months; 5 years
DPT 6,10,14 weeks; 16-18 months; 5 years
Hepatitis B Birth, 6 weeks, & 14 weeks or
6 weeks, 10 weeks & 14 weeks
Hib Conjugate 6 weeks, 10 weeks & 14 weeks
Measles 9 months; 16-24 months
MMR 15 months
Typhoid 2 years, 5 years, 8 years & 12 years
TT 10 & 16 years
TT Early in pregnancy & 4 weeks after TT-1

58. Vaccines that can be given after discussion with parents
 Varicella ---- 15 months
 Hepatitis A -- 18 months and 6 months later
 Influenza vaccine -- 6 months of age
 Pneumoccocal conjugate vaccine -- 6 weeks

59. 1) If a dose is missed……..
Give the dose at the next opportunity irrespective of the time gap
Do not start the schedule all over again

60. 2) If a not a single dose taken ?????
What next ??

62. 3) Immunisation in preterm infants
 All vaccines except Hepatitis B
 If BW < 2Kg & mother HBsAg negative :- postpone till baby attaines 2kg wt
or 2 mths of age.
 If BW < 2Kg & mother HBsAg positive :- give vaccine + immunoglobulin.

63. 4) Children receiving corticosteroids
Children receiving corticosteroids at the dose of 2 mg/kg/day for more
than 14 days should not receive live virus vaccines until steroid has
been discontinued for at least 1 month.

64. 5) Vaccination in HIV/AIDS

67. Tetanus toxoid
Intramuscular – upper arm – 0.5 ml
Pregnancy – 2 doses - 1st dose as early as possible and second dose after 4
weeks of first dose and before 36 weeks of pregnancy
Pregnancy – booster dose (before 36 weeks of pregnancy) – If received 2
TT doses in a pregnancy within last three years. Give TT to woman in
labour, if she has not received TT previously
TT booster for both boys and girls at 10 years and 16 years
No TT required between two doses in case of injury

68. BCG
At birth or as early as possible till one year of age
0.1 ml (0.05ml until one month of age)
Intra-dermal
Left upper arm

69. Hepatitis B
Birth dose – within 24 hours of birth
0.5 ml
Intramuscular
Antero-lateral side of mid-thigh
Rest three doses at 6 weeks, 10 weeks and 14 weeks

70. OPV
Zero dose – within first 15 days of birth
2 drops
Oral
First, second and third doses at 6, 10 and 14 weeks with DPT-1, 2 and 3
OPV booster with DPT booster at 16-24 months

71. DPT
Three primary doses at 6, 10 and 14 weeks with OPV-1, 2 and 3
0.5 ml
Intra-muscular
Antero-lateral side of mid-thigh
One booster at 16-24 m with OPV booster (antero-lateral side of
mid-thigh) and second booster at 5-6 years (upper arm)

72. Measles
At 9 completed months to 12 months
Give up to 5 years if not received at 9-12 months age
Second dose at 16-24 months (select states after catch-up campaign)
– Measles Containing Vaccine
0.5 ml
Sub-cutaneous
Right upper arm
Along with Vitamin A (1st dose) – 1ml (1 lakh IU) - oral

73. Constraints
 Illiteracy
 Non uniform coverage
 Poor implementation
 Poor monitoring
 High drop outs
 Declining coverage in some major states
 Over reporting
 Poor injection safety
 Reorientation of staff being not carried out

74.  Vacany of staff at field level not filled
 Poor surveillance of vaccine preventable diseases
 Poor vaccine logistics
 Poor maintainance of equipments
 Extra ordinary emphasis on polio vaccine

75. STATUS OF VPD -INDIA
DISEASE 1987 2011 %
DECLINE
POLIMYELITIS 28,257 1 100
DIPTHERIA 12,952 4,233 62.3
PERTUSIS 163,786 3,909 76.13
NNT 11,849 734 93.8
MEASLES 247,519 33,634 86.41

76. Achievements:
The biggest achievement of the immunization program is the eradication of
small pox.
India is free of Poliomyelitis caused by Wild Polio Virus (WPV) on 27 march
2014.
India declared free of maternal and neonatal TT in June 2015
Besides, vaccination has contributed significantly to the decline in the cases
and deaths due to the Vaccine Preventable Diseases (VPDs).

77. *PULSE POLIO IMMUNIZATION
1995.
Under 5 children.
Additional oral polio drops administered in
December & January.

79. On 25 Feb 2012
INDIA is removed from the list of
“POLIO ENDEMIC COUNTRIES”

80. Maternal & Neonatal TT status
 WHO declared that Maternal & Neonatal TT eliminated from India in 15 May
2015

82. Mission Indradhanush
 Launched on 25th dec 2014 by GOI.
 Aim :- To immunise all children against 7 preventable diseases by 2020
 Why?
 Where?

85. HOW?
1) Intensified routine immunisation campaigns
Special catch up campaigns
2) Micro planning of campaigns/sessions at all levels
3) Effective communication and social mobilisation efforts
4) Intensive training of health officials and frontline workers
5) Establish accountability framework through task forces

86. References
1) Immunization Handbook for Health Workers, New Delhi, Government of India, 2006,
(http://www.whoindia.org/LinkFiles/Routine_Immunization_Immunization_Handbook_for_Health_W
orkers_2006.zip),
2) Immunization In Practice: A Practical Resource Guide for Health Workers,Geneva, World Health
Organization, 2004, (WHO/IVB/04.06), (http://www.who.int/vaccines-documents/DoxTrng/h4iip.htm)
3) India National Universal Immunization Programme Review, New Delhi,
B(http://www.whoindia.org/LinkFiles/Routine_Immunization_Acknowledgements_contents.pdf)
4) Integrated Disease Surveillance Project: , Training Manual for State & District Surveillance Officers,
Module 5, New Delhi, Government of India, 2005,
(http://nicd.nic.in/IDSP_docs/TRAINING%20MANUAL/District%20Surveillance%20Team%20Training%
20Manual/Module5.pdf)
5) Measles Mortality Reduction: India Strategic Plan 2005-2010, New Delhi, Government of India, 2005,
(http://www.whoindia.org/LinkFiles/Measles_Measlespdf.pdf)
6) National Child Survival and Safe Motherhood Programme: Surveillance, New Delhi, Government of
India, 1994

87. 7) Field Guide: Measles Surveillance, &, Outbreak Investigation, New Delhi, Government of India,
2006, (http://www.npsuindia.org/download/Measles%20Guide.pdf)
8) Field Guide: Surveillance of Acute Flaccid Paralysis, New Delhi, Government of India, 2005,
(http://www.npspindia.org/download/Redbook.pdf)
9) Guidelines for Disposal of Bio-medical Waste Generated during Universal Immunization
Programme, Delhi, Central Pollution Control Board, 2004,
(http://www.solutionexchange-un.net.in/environment/cr/res21040602.doc)
10) Guidelines for Reporting & Management of Adverse Events Following Immunization: India, New
Delhi, Government of India, 2005,
(http://www.whoindia.org/LinkFiles/Routine_Immunization_AEFIguidelines_for_reporting.pdf)
11) Guidelines for Surveillance of Acute Encephalitis Syndrome, New Delhi, Government of India, 2006,
(http://nvbdcp.gov.in/Doc/AES%20guidelines.pdf)
12) Immunization Essentials: A Practical Field Guide, Washington, D.C., United States Agency for
International Development, 2003, (http://www.dec.org/pdf_docs/PNACU960.pdf)
13) Multi Year Strategic Plan 2005-2010: Universal Immunization Programme, New Delhi, Government
of India, 2005,
(http://www.whoindia.org/LinkFiles/Routine_Immunization_MYP_PDF_(o5_July_05)__Final.pdf)
14) National Family Health Survey (NFHS-3), 2005-06: India, Mumbai, International Institute of
Population Sciences and Macro International, 2007,
(http://nfhsindia.org/nfhs3_national_report.html)

88. 15)National Immunization Programme: Conduct Disease Surveillance, New Delhi, Government of
India, 1989
16)Outbreaks Investigation and Control, New Delhi, National Institute of Communicable Diseases,
Government of India, 1998, (2-313 DGHS/98)
17)Reproductive and Child Health Programme, Immunization Strengthening Project:Training Module
for Mid-level Managers, New Delhi, Government of India, 2001
18)Standard Operating Procedures for Investigation of Adverse Events Following Immunization, New
Delhi, Government of India, 2005,
(http://www.whoindia.org/LinkFiles/Routine_Immunization_standard_operating_procedures.pdf)
19)Surveillance of Epidemic-Prone Diseases, New Delhi, National Institute of Communicable Diseases,
Government of India, 1998, (2-312 DGHS/98)
20)Training for Mid level Managers Modules (MLM), Geneva, World Health Organization, 2008
(http://www.who.int/immunization_delivery/systems_policy/training/en/index1.html)

89. THANK U !!!